FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/01/039834 [Registered on: 31/01/2022] Trial Registered Prospectively
Last Modified On: 28/01/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   To control intraoperative blood pressure and heart rate changes 
Scientific Title of Study   A prospective, randomised study to assess the haemodynamic changes in patient undergoing laparoscopic cholecystectomy under general anaesthesia with transversus abdominis plane block while creating pneumoperitoneum 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Negi Deeksha 
Designation  Junior Resident 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Room no 61 Second floor Department of Anesthesiology RIMS Ranchi

Ranchi
JHARKHAND
834009
India 
Phone  7016368230  
Fax    
Email  deekshanegi94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Negi Deeksha 
Designation  Junior Resident 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Room no 61 Second floor Department of Anesthesiology RIMS Ranchi

Ranchi
JHARKHAND
834009
India 
Phone  7016368230  
Fax    
Email  deekshanegi94@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Ekramul Haque 
Designation  Associate Professor 
Affiliation  Rajendra Institute of Medical Sciences 
Address  Room no 62 Second floor Department of Anesthesiology RIMS Ranchi

Ranchi
JHARKHAND
834009
India 
Phone  8210696628  
Fax    
Email  ekramrims@yahoo.co.in  
 
Source of Monetary or Material Support  
Department of Anesthesiology, RIMS, Ranchi 
 
Primary Sponsor  
Name  Rajendra Institute of Medical Sciences 
Address  Department of Anesthesiologyz RIMS, Ranchi 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Negi Deeksha  Rajendra Institute of Medical Sciences  2nd floor, Department of Anesthesiology, RIMS, Ranchi
Ranchi
JHARKHAND 
7016368230

deekshanegi94@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Rajendra Institute of Medical Sciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Bupivacaine 0.25%  Effect of 20 ml of 0.25% Bupivacaine, bilateral Transversus abdominis plane block for 12 hrs 
Comparator Agent  Normal saline 0.9%  Effect of 20 ml of 0.9% Normal Saline, bilateral Transverse abdominis plane block for 12 hours 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient posted for laparoscopic cholecystectomy of ASA 1 and 2 status between the age of 18 to 60 years not on anticoagulant or antiplatelet drug 
 
ExclusionCriteria 
Details  Patient not willing to consent, history of allergy to study drug, having coagulation disorder or uncontrolled hypertension. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare whether bilateral Transversus abdominis plane block with 0.25% bupivacaine given in the study group just after induction can alleviate haemodynamic changes in laparoscopic cholecystectomy while creating pneumoperitoneum with control group who are receiving 0.9% normal saline in Transversus abdominis plane block  Before induction,
just before pneumoperitoneum,
immediately after pneumoperitoneum,
5 minutes
10 minutes
15 minutes
20 minutes
25 minutes
30 minutes  
 
Secondary Outcome  
Outcome  TimePoints 
To observe analgesia in post laparoscopic cholecystectomy patients using visual analogue scale in both group  1 hour
4 hour
8 hour
12 hour 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   01/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  Publication

  6. For how long will this data be available start date provided 01-02-2022 and end date provided 01-02-2023?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary   AIMS AND OBJECTIVES
AIM: - The aim is to find out whether bupivacaine delivered, after general anaesthesia, bilaterally through transversus abdominis plane (TAP) block in lap cholecystectomy helps in preventing hemodynamic changes while creating pneumoperitoneum.
OBJECTIVES:-
PRIMARY OBJECTIVE
To compare whether bilateral TAP block with 0.25% bupivacaine given in the study group just after induction can alleviate hemodynamic changes in lap cholecystectomy while creating pneumoperitoneum with control group who are receiving normal saline in TAP block.
SECONDARY OBJECTIVE
To observe analgesia in post laparoscopic cholecystectomy patients using Visual Analogue Scale in both groups.
 
MATERIALS AND METHODS
STUDY DESIGN: - a double blinded prospective randomized study
SITE OF STUDY: - Rajendra Institute of Medical Sciences, Ranchi
DURATION OF STUDY: - One and a half year from the time of approval by the research and ethics committee
METHOD OF RANDOMISATION: - The patient will be divided into two groups by computer generated randomization.
Opaque sealed envelopes will be used to conceal the group assignment.
GROUP B - this case group will receive general anaesthesia along with 0.25% bupivacaine 20 ml on each side by TAP block technique.
GROUP C – this control group will receive general anaesthesia along with normal saline 20 ml on each side by TAP BLOCK technique.
SAMPLE SIZE: - 25 cases in each group
INCLUSION CRITERIA:-
1. Patient posted for laparoscopic cholecystectomy
2.  Age between 18-60 years of both gender.
3.  Patient willing to give written informed consent.
4. ASA (American society of anesthesiologist) physical status Ι and II
5.Patient not on any antiplatelet or anticoagulation drug.
EXCLUSION CRITERIA:-
1.PATIENT refusal for procedure
2.Age less than 18 and more than 60 years
3.Coagulation disorder
4.Allergy to local anaesthesia
5.Uncontrolled hypertensive patients
 
METHODOLOGY
Written consent from the patient will be taken.
Pre anaesthetic check-up will be done a day before surgery including detailed history, thorough physical examination and systemic examination.
Routine investigations including complete blood count, routine urine examination, electrocardiogram, serum urea, serum creatinine, random blood sugar and chest radiograph PA view.
The patient will be kept nil per oral for 8 hours.
In the operation theatre, monitors like pulse oximeter, electrocardiogram leads, non invasive blood pressure and end tidal carbon dioxide will be used throughout the operation.
Baseline vitals will be noted.
The patient will be preoxygenated for 3 minutes with 100% oxygen. Then pre-medicated with midazolam (0.02 mg/kg) followed by fentanyl (2mcg/kg)
Induction will be done with 1% propofol (2mg/kg) and intubated with endotracheal tube after giving atracurium (0.5 mg/kg).
Maintenance will be done by oxygen, nitrous oxide and sevoflurane with
1 MAC along with maintenance dose of atracurium.
Subjects who will be randomised to GROUP B will receive landmark guided B/L TAP block with 0.25% bupivacaine 20 ml on each side.
While Group C will receive B/L TAP block with 20 ml N.S. on each side.
The landmark-guided technique applies loss of resistance as the needle is advanced through the fascia layers of external oblique and internal oblique [6].
After locating the triangle of Petit[7] which is bounded by the latissimus dorsi posteriorly, the external oblique anteriorly and iliac crest inferiorly, the TAP is identified using the double-pop loss of resistance technique. The first pop indicates penetration of the fascia of the external oblique muscle, and the second indicates piercing of the fascia of internal oblique and entry of the needle into the TAP[8].
When the tip of needle is placed between internal oblique and transversus abdominis muscle, after negative aspiration of blood to exclude vascular puncture, drug will be injected 20ml of 0.25% bupivacaine on each side.
We will wait for 15 minutes after the TAP block before the use of Veress needle or Hasson trocar for establishment of pneumoperitoneum.
We will observe heart rate and systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) before creating pneumoperitoneum and after 5, 10, 15, 20, 25 and 30 minutes of creating pneumoperitoneum.
Patients of both the groups will be observed after 1, 4, 8 and 12 hours in ward after surgery for pain assessment. Visual Analogue Scale (VAS) will be used to access pain.
The time for first rescue analgesia and time for VAS score to be 4 or more will be noted. For rescue analgesia DICLOFENAC (1 mg/kg) will be given intra-muscularly (max dose 150 mg).
My study on a patient will end at the time when first rescue analgesia will be given.
STATISTICS
Data will be summarized as mean and standard deviation for numerical variables and count and percentages for categorical variables. For statistical analysis data were entered into a Microsoft excel spreadsheet and then analyzed by SPSS software. For qualitative data, Chi square test will be used to observe the difference between two proportions for the paired value. For quantitative data, student t-test will be used, and data will be expressed by the mean and standard deviation (SD) of the difference between two means for paired observations. P-value < 0.05 will be considered statistically significant.
 Sample size is calculated as 24.75 ~ 25 approximately in each group by using the formula:
n = 16 pq/d2
where n= sample size per group, P1 = 35% or 0.35, P2= 75% or 0.75
Taking 5% as level of significance and 80% as power of study.

 
Close